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ABSTRACT
About 15% of human colorectal cancers and,
at varying degrees, other tumor entities as well as
nearly all tumors related to Lynch syndrome are
hallmarked by microsatellite instability (MSI) as
a result of a defective mismatch repair system.
The functional impact of resulting mutations
depends on their genomic localization. Alterations
within coding mononucleotide repeat tracts
(MNRs) can lead to protein truncation and formation
of neopeptides, whereas alterations within
untranslated MNRs can alter transcription level or
transcript stability. These mutations may provide
selective advantage or disadvantage to affected
cells. They may further concern the biology of
microsatellite unstable cells, e.g. by generating
immunogenic peptides induced by frameshifts
mutations. The Selective Targets database
(http://www.seltarbase.org) is a curated database
of a growing number of public MNR mutation
data in microsatellite unstable human tumors.
Regression calculations for various MSI–H tumor
entities indicating statistically deviant mutation
frequencies predict TGFBR2, BAX, ACVR2A and
others that are shown or highly suspected to be
involved in MSI tumorigenesis. Many useful tools
for further analyzing genomic DNA, derived wild-
type and mutated cDNAs and peptides are
integrated. A comprehensive database of all
human coding, untranslated, non-coding RNA- and
intronic MNRs (MNR_ensembl) is also included.
Herewith, SelTarbase presents as a plenty instru-
ment for MSI-carcinogenesis-related research,
diagnostics and therapy.
INTRODUCTION
The completion of the human genome project in 2003
provided the data basis for genome-wide analyses (1).
Now it became within reach to systematically investigate
the whole human genome for sequence motifs or
structures by computer assisted investigation to clarify
the association of genome variation or mutation with
certain human diseases using the human genome draft as
a consensus. Currently, there are more than 22000 known
protein-coding genes annotated within the  3G of base
pairs within Human Ensembl (rel. 55.37, http://www
.ensembl.org/Homo_sapiens/) leading to more than
100000 transcripts. Sequence motifs of special interest
comprise single nucleotide polymorphisms (SNPs), splice
site recognition patterns or promoter motifs, regulatory
motifs and binding sites.
The human genome sequence also facilitated the sys-
tematic search for human microsatellites that had been
started earlier based on EMBL DNA and mRNA data
(2). Microsatellites are especially prone to deletion and
insertion mutations during DNA replication with a
strong dependency of mutability from their length (3).
They are distributed non-randomly throughout the
whole human genome within non-coding and coding
regions(4). Their function, however, is nearly unknown.
Mononucleotide repeats (MNRs) seem to represent
the most interesting kind of microsatellites. The length
of coding MNRs (cMNRs) is conserved (5). Length
alterations of cMNRs of 1 or 2 nucleotides lead to
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however can vary highly from individual to individual.
However, there are also a number of so-called quasi-
monomorphic MNRs of higher length (20–40bp) within
non-coding regions that show a signiﬁcantly restricted
length variation within the human population which
may indicate the possibility of functional relevance of
these non-coding MNRs. It is well known, that alterations
in polypyrimidine MNRs in the 50 local neighborhood of
splice donor sites can lead to exon skipping (6,7), which
will result in a frameshift situation in two-thirds (8). In
addition, shortening or elongation of MNRs within 50
UTRs can have an impact on the transcription level, of
those in the 30 UTR on transcript stability of the respective
mRNA (9).
Microsatellite alterations are corrected by the DNA
mismatch repair system (MMR). The functional inactiva-
tion of the MMR system results in the manifestation
of microsatellite mutations which is termed ‘microsatellite
instability’ (MSI). The MSI phenotype is found in >90%
of tumors developing in MMR germline mutation carriers
among hereditary non-polyposis colorectal cancer
(HNPCC) or Lynch syndrome patients and  15% of
sporadic cancers (10). Colorectal MSI–H tumors are
characterized by certain clinico-histopathological pro-
perties such as a better prognosis compared to tumors
of the CIN phenotype (11–13). Moreover, a dense lym-
phocyte inﬁltration is a characteristic feature of MSI–H
colorectal cancer (14,15). There is evidence that the
obviously enhanced immunogenicity of MSI–H cancers
may be caused by the generation of immunogenic
peptides. Insertion/deletion mutations at coding
microsatellites lead to a shift of the translational reading
frame and thus may lead to the translation of frameshift
peptides (neopeptides) that can be recognized as foreign
neoantigens by the host’s immune system (16,17),
reviewed in (18). Frameshift peptides may be generated
once the MMR system is inactivated, but maybe as early
as haploinsuﬃciency of one MMR gene becomes relevant
which might be assumed by the ﬁnding of immune
response against frameshift-induced neopeptides in
healthy HNPCC mutation carriers without any history
of tumor development (19). Notwithstanding, the MSI is
assumed to be the underlying mechanism for the further
malignant transformation and evolution of these tumors.
The identiﬁcation of the relevant genes among the mul-
titude of all genes is a key for understanding this process
and may reveal target structures for both diagnostic
and therapeutic concepts. Since the observed mutation
frequencies of MNRs of the same type and length
widely scatter (20), positive or negative selection processes
in aﬀected cell clones are held to be responsible for that
ﬁnding. Growth-promoting alterations are assumed to
show up with higher frequencies than coincidental
mutational events without eﬀect in so-called bystander
genes. In contrast, alteration of genes of proteins with
essential cellular functions is supposed to emerge with a
reduced mutation frequency. A recently developed statis-
tical model aims to identify positive and negative selected
targets (PSTs and NSTs, in short) (20). A signiﬁcant devi-
ation from the average mutation rate in respect to a given
MNR length will mark oﬀ genes with elevated or reduced
mutation frequency, classifying them either as PSTs or
NSTs.
Since closing of data collection for the original
described model (20) we continued the extensive literature
review on data concerning genes with coding and non-
coding MNRs and their mutation rate in MSI–H
colorectal, gastric or endometrial cancer samples by also
parsing detail information and recruitment of other data
sources, that is public databases, e.g. the Cancer Genome
Project. All these data were organized in a relational
database with an easily readable web interface. All
MNR detail data included within SelTarbase are cross-
linked with important genomic and protein information
sources at EMBL, NCBI, SBI and many more, providing
quick connections for sequence-related information.
Especially with regard to the possible immunologic
impact of cMNR mutations we developed some useful
tools [prediction of frameshift transcripts and peptides,
presentation of the resulting neopeptides, forecast of
nonsense-mediated RNA decay (NMD) sensitivity] for
the deduction of possible implications of the underlying
mutation.
DATA MINING AND EVALUATION
The ﬁrst extensive survey of the literature (April 2002)
revealed 110 publications referring to mutation analyses
of 245 coding and non-coding microsatellites in 177 genes
either in MSI-H colorectal, gastric or endometrial cancer.
This provided the basis for SelTarbase version 2003 (20).
The PubMed (http://www.ncbi.nlm.nih.gov/sites/entrez?
db=PubMed) is routinely screened once per week for
search terms (microsatellite instability, MSI, MMR and
HNPCC). Manuscripts, of which title or abstract
contain evidence for MNR mutation data, are analyzed
as full text.
Detailed information about statistical methods and
parameters as well as the regression model and software
used are available via the online help: Help and Docu-
mentation at http://www.seltarbase.org/?topic=help.
Core database
SelTarbase core database currently contains approxi-
mately 40000 records (version latest, 21st release,
200908) concerning mutational data of more than 3400
MNRs from about 400 human genes derived from
approximately 500 publications. With the release 201001
a larger number of more than 100 longer, mostly
coding MNRs will become available (S.M. Woerner
and S. Korﬀ, unpublished data). In total, this corresponds
to about 220000 single observations combining all
four entities [colon (incl. rectum), stomach, endometrium
and colon culture]. The home page of SelTarbase pre-
sents information about the current database content
regarding the number of references that were screened
for MNR mutation data and how many of them have
been included, the number of genes and MNRs each
stratiﬁed by entity. Alongside the same parameters of
the previous release (version last) are compared to give a
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release (version latest). Most data are derived from colon
tumor analysis followed by stomach, endometrium and
colon culture at nearly comparable level.
SelTarbase prediction
SelTarbase prediction facilitates the assigning of statisti-
cally deviant mutation frequencies based on our
previously published model (20). For the four entities
colon, stomach, endometrium and colon culture individ-
ual result tables are built up. Based on these, sigmoid
regression calculations are performed to generate a mean
mutation approximation depending on MNR length. For
detailed information about the regression model see the
online help: Help and Documentation at http://www
.seltarbase.org/?topic=help. Figure 1 shows the graphical
output of the sigmoid regression analysis for colon. Of the
1793 MNRs included in this regression analysis, 47 are
signiﬁcantly higher and 23 are signiﬁcantly lower
mutated than the average and predicted as PST or NST
genes. The proportion of signiﬁcantly deviating MNRs
therefore is 4.0% for colon (3.9% for stomach, 3.7% for
endometrium and 2.5% for colon culture).
Human MNR database: MNR_ensembl
MNR_ensembl is a comprehensive database containing
coding, untranslated, non-coding RNA- and intronic
MNRs within the human genome. It currently contains
approximately 558000 cMNRs, 874000 uMNRs, 3700
ncrMNRs and 25400000 iMNRs of length x 4. Due to
alternative splicing the complete number of MNRs within
coding, untranslated, and intronic regions of the human
genome is approximately 26500000 (Ensembl rel. 55.37).
A somewhat older version of all mouse c/u/iMNRs is also
available (mouse rel. 45.36f).
MNR_ensembl is fully integrated within SelTarbase
including the possibility to use the transcription and trans-
lation information function, thus it is easy to have a look
Figure 1. Graph of sigmoid regression analysis. Result of colorectal cancer mutation data: ncMNRs (non-coding i.e. untranslated, intronic and
pseudogene MNRs, open diamonds), cMNRs (amino acid coding MNRs, grey ﬁlled circles), and nMNRs (intergenic MNRs, open squares). Red
marked MNRs changed since previous release, respectively represent new data. Regression analysis was performed combined for all MNR types. The
ﬁtted regression line is drawn as solid black line, the upper and lower prediction lines as bold dashed grey lines. If the pointing device is moved over
data points that reside above the upper respectively below the lower prediction line, a popup will appear, showing the name of the gene and the
mutation frequency as well as the number of analyzed tumor samples. If the pointing device is moved over the ﬁtted regression line (solid black line),
a popup will appear, showing the length   with the corresponding mean mutation frequency as well as the lower and upper prediction thresholds for
the length  .
D684 Nucleic AcidsResearch, 2010, Vol.38,Database issueat all possible frameshift transcripts and peptides as well
as the prediction of NMD sensitivity for any human
cMNR.
Web interface
SelTarbase is based on a relational database built with
MySQL. The web interface was implemented with perl
cgi-scripts. The database can be searched for gene
names, tract pseudonyms (e.g. BAT26), accession
numbers (EMBL, Ensembl, Entrez Gene and Unigene),
gene description (MNR_ensembl), author names, title,
PubMed ID and DOI as well as colorectal cancer cell
line names. Scrolling through MNR detail data can be
customized by limiting the list to single contributing
references or by coding status and MNR length (even in
combination). MNR contribution of references can also
be shown as alphabetically ordered MNR lists grouped by
the initial of the gene name.
Figure 2a and b exemplarily show the MNR detail data
of the A10 cMNR (BATRII) within the TGFBR2 gene.
Following information is provided: MNR type (nucleotide
and length, reported length if diﬀering), coding status, the
reference ﬁrstly reported data for this MNR (ordered by
publication year and PubMed ID), accession number of
EMBL, Ensembl, Entrez Gene and Unigene. All accession
numbers are linked to the respective databases at
EBI (http://www.ebi.ac.uk/embl), EMBL (http://www
.ensembl.org/Homo_sapiens) and NCBI (http://www
.ncbi.nlm.nih.gov/sites/entrez, http://www.ncbi.nlm.nih
.gov/UniGene). Furthermore, there are links to other
useful gene information databases: SOURCE (http://
source.stanford.edu), SMART (http://smart.embl-
heidelberg.de/smart), GermOnline (http://www
.germonline.org/Homo_sapiens), GeneCards (http://www
.genecards.org) and SAGE (http://cgap.nci.nih
.gov/SAGE), followed by the entity related mutation
frequencies and contributing sample numbers including
information of the contributing references. The next para-
graph presents the genomic sequence surrounding the
MNR (with BLASTN option using the currently linked
Ensembl genome), PCR primers for fragment or sequence
analysis of this MNR—if available, as well as the tran-
script sequence surrounding the MNR in case of coding or
untranslated MNRs. In addition, all known Ensembl
transcripts of the corresponding gene are listed together
with information about the transcription and translation
status of the MNR, the ATG-, the stop codon- and the
MNR-position. For each listed Ensembl transcript/
peptide a link to the LOCATE subcellular localization
database (http://locate.imb.uq.edu.au) is provided.
Finally, all known mutation information of MSI–H
colorectal cancer cell lines available appears in detail.
The allele status of coding MNRs—if exactly known—
will link to another SelTarbase function that is shown in
Figure 3: MNR transcription and translation information
at sequence and amino acid level. All annotated Ensembl
transcripts and the corresponding frameshift sequences (1
respectively 2-nt insertion/deletion), and the amino acid
sequences derived thereof are shown. This function
provides tools to perform a BLASTP of frameshift
peptides via NCBI (http://www.ncbi.nlm.nih.gov/blast)
and ExPASy (http://www.expasy.org), to calculate the
molecular weight of wild-type and mutated peptides/
proteins at ExPASy, and to export nucleotide and
peptide sequences in FASTA format for further usage.
Moreover, this function displays theoretical information
about degradation by NMD as NMDs (sensitive), NMDu
(unknown) or NMDi (insensitive) for each of the
frameshift transcripts. In case of missing cell line data,
this function is also available with the option of all four
theoretical allele types (minus 2, minus 1, plus 1 and plus
2) as prelinked from the MNR information page, in order
to be able to check predicted transcripts and frameshift
peptides in the same way.
There is also the possibility to register with SelTarbase.
Registration is free for all users and allows for usage of
higher CPU-consuming functions e.g. model recalculation
and searching the MNR database MNR_ensembl. It can
be searched in whole or in part (coding, untranslated, non-
coding RNA- and/or intronic MNRs) for Ensembl acces-
sion numbers (ENSG), hugoIDs, or keywords of the short
gene description provided with the gene name within
Ensembl (Figure 4). More detailed information is given
in legend of Figure 4.
An additional useful feature of SelTarbase is the possi-
bility to upload new user mutation data in order to have
the regression recalculated including these unpublished
data. Data can be provided with a minimum of informa-
tion not to disclose unpublished data using a self-chosen
name, the nucleotide type and length and a virtual
position as MNR ID. If one intends to complement data
already included within Seltarbase, then it is recom-
mended to apply the exact MNR name used in
SelTarbase in order to correctly collate these data. This
tool is able to process data uploaded from diﬀerent
platforms/operating systems and also to provide result
ﬁles usable on diﬀerent platforms without the need of
special software, packed in the user’s suitable format
(zip, rar, tar and bz2).
Documentation and help for all applications included
within SelTarbase is available through the web interface.
FUTURE PROSPECTS AND UPDATES
Regression calculation is updated monthly provided that
new includable data becomes available. The human
MNR tables (MNR_ensembl) as well as the underlying
human genome and transcripts are subsequently updated
whenever a new Ensembl release will be provided (usually
four times a year). The coding status of each MNR
included or reported within MNR_ensembl relies on the
respective Ensembl release mentioned within SelTarbase
(currently rel. 55.37).
The inclusion of further entities (colon adenoma,
urothelial and ovarian cancer) is primed within
SelTarbase and will become available as soon as suﬃcient
data are available for a reliable regression analysis of these
entities. Additionally, the implementation of further tools
for characterizing frameshift transcripts and peptides is in
progress.
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Since human tumors showing MSI considerably diﬀer
in a number of clinical as well pathologic parameters
from tumors showing chromosomal instability, the MSI
phenotype is of very high concern regarding tumorigenesis
(11–13) and immunology (18). The functional loss of the
mismatch repair capacity—acquired or inherited—is the
initial step; a huge number of mutation manifestations
spread all over the genome is the consequence (21–23).
Figure 2. The MNR detail information page. Most details are mentioned within the 2nd paragraph of section Web Interface. Using the buttons
‘MNR’ or ‘Reference’ several ﬁlters can be deﬁned for scrolling from MNR to MNR, either restricting to MNRs of one contributing reference and/
or regarding coding status and MNR length. Filters can be used in combination. If the pointing device is moved over cell line names, a popup will
appear, showing additional information regarding this cell line including links to publications from which this information is drawn (Supplementary
references of SelTarbase).
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advantage for malignant transforming/transformed cells is
believed to be the driving force of MSI tumorigenesis
(20,24). However, due to the mentioned diﬀerences
between CIN and MSI tumors certain aﬀected genes
may share. But, the pivotal players of MSI tumorigenesis
can be investigated using a diﬀerent strategy. As an addi-
tional point MSI tumors represent a certain variation of
human tumors by the generation of tumor-speciﬁc
neoantigens. Frameshift peptides (neopeptides) resulting
from numerous coding MNR mutations are providing a
special immunologic situation maybe explaining the better
prognosis of MSI tumors compared to CIN tumors.
Taken together, systematic and profound information
about human microsatellites would be of great value for
scientiﬁc, diagnostic and therapeutic purposes.
Since 1995 a number of genes suspected to be involved
in MSI tumorigenesis by MNR mutations [e.g. TGFBR2,
BAX and others (25,26)] were described, and more or less
intensely characterized. As functional evidence for the
consequence of MNR mutations within those genes is dif-
ﬁcult to show, the mutation frequency often was used as a
clue for the transformation impact. However, mutation
rates of MNRs widely scatter. Hence, the question was
how to diﬀerentiate suspicious from average-mutated
MNRs. Therefore, diﬀerent attempts were undertaken to
identify the key players of MSI tumorigenesis. We
developed a statistical model in order to accomplish
such a discrimination (20). Since 2003 the basic data set
tremendously increased and mathematics were adapted
accordingly. As a result of the regression analysis, from
the very ﬁrst beginning of the model up to now, genes such
as TGFBR2, BAX and ACVR2A with the highest evidence
for a MSI-tumorigenesis driving force show a signiﬁcantly
elevated mutation frequency in MSI–H gastrointestinal
cancer. Meanwhile, there are some other genes showing
signiﬁcantly increased mutation frequencies by the regres-
sion analysis included within SelTarbase, for which more
and more evidence for an involvement in MSI
tumorigenesis is emerging, such as EPHB2, MRE11A,
MYH11 and TCF-4 (27–30).
SelTarbase is a comprehensive curated mutation data
collection of human MSI-H tumor and colorectal cell line
data. This information is systematically organized and
Figure 3. Transcription and translation information page: transcripts/peptides are scrollable from 50 to 30 using diﬀerent units of 10–500bp (default
50bp). When the page is loaded all MNR containing transcripts are aligned according to MNR position showing the MNR at the left border of the
sequence window. Transcripts that do not contain the MNR are greyed, and no frameshift information is calculated. More information about this
function is provided within the 2nd paragraph of section Web Interface.
Nucleic Acids Research, 2010,Vol.38, Database issue D687straightforward accessible. Being routinely revised and
extended it always provides an up-to-date resource of
known (public) data for the community as simple informa-
tion, for data or sample controlling, or helping to prevent
from multiple analysis. The superimposed regression
analyses may help researchers to focus functional
investigations of MSI-related genes by superseding
additional time- and money-consuming analyses. Within
SelTarbase integrated tools, e.g. the prediction of frame-
shift transcripts and peptides or the prediction of
transcripts regarding NMD may further assist the
decisionprocessortheinvestigationoutlineofforthcoming
immunology related experiments. The systematic infor-
mation of and the prediction tools implemented may
also facilitate the selection progression of appropriate
candidates for vaccination and other diagnostic or
therapy-related options. For new, unpublished MNR
mutation data submission and recalculation of the regres-
sion analysis may be supportive to classify the candidate(s)
within the number of already known MNR data. As
further part of SelTarbase, MNR_ensembl provides a
current, complete database of all human coding,
untranslated, other non-coding and intronic MNRs as
potential targets of MSI in MSI-H tumors and cell lines
based on the current human genome included within the
Ensembl database (Homo sapiens, rel. 55.37) and may lead
to direct mutation analyses of new highly promising can-
didategeneswithouttheneedofownbioinformaticutilities
and capabilities. Taken together, SelTarbase opens a
broad variety of possibilities to researchers committed in
the ﬁeld of MSI tumorigenesis, diagnostics and therapy.
Availability
SelTarbase is available at http://www.seltarbase.org. Data
can be retrieved as html as well as downloaded as plain
text ﬁles.
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